Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma Group (MREO) Cost of Revenue: 2023-2025

Historic Cost of Revenue for Mereo BioPharma Group (MREO) over the last 1 years, with Jun 2025 value amounting to $32,000.

  • Mereo BioPharma Group's Cost of Revenue was N/A to $32,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $3.4 million, marking a year-over-year change of. This contributed to the annual value of $2.6 million for FY2023, which is 124.61% up from last year.
  • Per Mereo BioPharma Group's latest filing, its Cost of Revenue stood at $32,000 for Q2 2025, which was up 111.72% from -$273,000 recorded in Q4 2023.
  • Over the past 5 years, Mereo BioPharma Group's Cost of Revenue peaked at $3.4 million during Q2 2023, and registered a low of -$273,000 during Q4 2023.
  • For the 2-year period, Mereo BioPharma Group's Cost of Revenue averaged around $754,200, with its median value being $235,000 (2023).